Focus on the Kryptonite cannabis strain
The Kryptonite is a strain created by growers at the University of Oaksterdam in California’s Bay Area. It is an Indica-dominant hybrid known for producing THC levels exceeding 25%. Kryptonite is intended for people seeking to treat severe pain without experiencing the drowsiness associated with certain pure Indica strains.
This variety is very sweet and has a strong aroma of tropical fruits, particularly mango and pineapple. The KRyptonite has a sweet aroma, but it can be a bit pungent.
Kryptonite has proven effective in helping patients suffering from inflammation and chronic muscle pain. In addition, this strain induces a sense of calm and euphoria in users, as well as a feeling of well-being.
Features of Kryptonite
Name : Kryptonite
Type: Indica-dominant hybrid (85/15)
THC content : 25 to 28%
Origin : California (Northern California)
Positive effects: Euphoric, Relaxing, Uplifting.
Medical effects: Relieves stress and pain; effective against headaches and insomnia.
Negative effects: Extreme lethargy, anxiety, some dizziness, and paranoia
A cannabis testing laboratory, Analytical 360 has tested a sample of the strain. The results showed a THC content of up to 28.501%. Patients will benefit from this strain, which contains a lot of active terpenes and cannabinoids. The synergistic interaction between Kryptonite’s active compounds provides a beneficial and effective treatment for patients suffering from stress-related conditions.
This strain should not be confused with Kryptonite OG; this cloned version is different because it has a purple phenotype. This strain features bright flashes of fuchsia.
Mehdi Bautier
-
Cannabis in Africa1 week ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France1 week ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France1 week ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean1 week ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Business3 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabinoids1 week ago
Japan bans CBN
-
Business1 week ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Cannabis in the U.S.1 week ago
Trump's reclassification of cannabis is being challenged in court


You must be logged in to post a comment Login